These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2010079)

  • 41. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
    Darioli R; Bovet P; Brunner HR; Bercher L
    Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
    Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L
    Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statin therapy in clinical practice: new developments.
    Shepherd J
    Curr Opin Lipidol; 1995 Oct; 6(5):254-5. PubMed ID: 8520846
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
    Farnier M; Bonnefous F; Debbas N; Irvine A
    Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
    Aronson JK; Ng LL
    Q J Med; 1990 Feb; 74(274):111-5. PubMed ID: 2111916
    [No Abstract]   [Full Text] [Related]  

  • 47. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.
    Kamisako T; Adachi Y
    Am J Gastroenterol; 1995 Jul; 90(7):1187-8. PubMed ID: 7611234
    [No Abstract]   [Full Text] [Related]  

  • 48. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 49. [The cholesterol hypothesis has been proved true at last].
    Huttunen J
    Duodecim; 1995; 111(5):385-6. PubMed ID: 8674438
    [No Abstract]   [Full Text] [Related]  

  • 50. [Rhabdomyolysis due to simvastin. Apropos of a case with review of the literature].
    Dromer C; Vedrenne C; Billey T; Pages M; Fournié B; Fournié A
    Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):281-3. PubMed ID: 1496277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute cholestatic hepatitis during simvastatin administration.
    Ballaré M; Campanini M; Catania E; Bordin G; Zaccala G; Monteverde A
    Recenti Prog Med; 1991 Apr; 82(4):233-5. PubMed ID: 1857844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.
    Barth JD; Kruisbrink OA; Van Dijk AL
    BMJ; 1990 Sep; 301(6753):669. PubMed ID: 2224231
    [No Abstract]   [Full Text] [Related]  

  • 53. Simvastatin-induced protein-losing enteropathy.
    Chagnon JP; Cerf M
    Am J Gastroenterol; 1992 Feb; 87(2):257. PubMed ID: 1734709
    [No Abstract]   [Full Text] [Related]  

  • 54. [The hypotriglyceridemic action of the combination of L-carnitine + simvastatin vs. L-carnitine and vs. simvastatin].
    Savica V; Bellinghieri G; Lamanna F
    Clin Ter; 1992 Jan; 140(1 Pt 2):17-22. PubMed ID: 1559317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge.
    Pezzilli R; Ceciliato R; Corinaldesi R; Barakat B
    Dig Liver Dis; 2004 Sep; 36(9):639-40. PubMed ID: 15460851
    [No Abstract]   [Full Text] [Related]  

  • 56. Myxoedema revealed by simvastatin induced myopathy.
    al-Jubouri MA; Briston PG; Sinclair D; Chinn RH; Young RM
    BMJ; 1994 Feb; 308(6928):588. PubMed ID: 8148686
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of hepatitis caused by simvastatin].
    Feydy P; Bogomoletz WV
    Gastroenterol Clin Biol; 1991; 15(1):94-5. PubMed ID: 2010080
    [No Abstract]   [Full Text] [Related]  

  • 58. Skin lesions due to treatment with simvastatin (Zocor).
    Feldmann R; Mainetti C; Saurat JH
    Dermatology; 1993; 186(4):272. PubMed ID: 8513195
    [No Abstract]   [Full Text] [Related]  

  • 59. Prenatal exposures to lovastatin and simvastatin.
    Lione A
    Reprod Toxicol; 1997; 11(4):641-2. PubMed ID: 9241687
    [No Abstract]   [Full Text] [Related]  

  • 60. Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy.
    Manson JM; Freyssinges C; Ducrocq MB; Stephenson WP
    Reprod Toxicol; 1996; 10(6):439-46. PubMed ID: 8946557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.